Related Experiment Video
Updated: Aug 17, 2025

06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
12.7K
In vitro models to study Clostridioides difficile infection: current systems and future advances.
Duncan Ewin1, William Davis Birch2, Ines B Moura1
1Healthcare-Associated Infections Group, Leeds Institute of Medical Research, Faculty of Medicine and Health.
Current Opinion in Gastroenterology
|December 12, 2022
Summary
In vitro models are advancing to better simulate Clostridioides difficile infection (CDI), offering improved insights into this urgent healthcare threat. These evolving models provide more physiologically relevant environments for studying CDI pathogenesis and potential treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Clostridioides difficile infection (CDI) is a significant healthcare-associated diarrheal illness, posing an urgent threat.
- Traditional in vivo animal models have limitations in accurately reflecting human CDI due to physiological differences.
- In vitro models offer enhanced control and the potential to use human ex-vivo cells for studying CDI.
Approach:
- Investigating the challenges of simulating the colonic environment in vitro.
- Evaluating bacterial fermentation models for therapeutic testing and microbiota research.
- Exploring co-culture models of human and bacterial cells, despite differing environmental requirements.
Key Points:
- Recent advancements enable longer culture times and more representative bacterial populations in in vitro models.
- Bacterial fermentation models, while useful, currently lack scalability for widespread adoption.
- Co-culturing human and bacterial cells presents challenges due to distinct cellular condition needs.
Conclusions:
- Evolving in vitro models are becoming more physiologically relevant for simulating CDI.
- These advanced models enhance the study of CDI pathogenesis and therapeutic development.
- The expanding applicability of in vitro models promises improved understanding and management of CDI.

